SOX6
Basic information
Region (hg38): 11:15966449-16739591
Links
Phenotypes
GenCC
Source:
- Tolchin-Le Caignec syndrome (Moderate), mode of inheritance: AD
- complex neurodevelopmental disorder (Definitive), mode of inheritance: AD
- Tolchin-Le Caignec syndrome (Strong), mode of inheritance: AD
- Tolchin-Le Caignec syndrome (Strong), mode of inheritance: AD
- Tolchin-Le Caignec syndrome (Strong), mode of inheritance: AD
- Tolchin-Le Caignec syndrome (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Tolchin-Le Caignec syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 32442410 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (150 variants)
- Inborn_genetic_diseases (79 variants)
- Tolchin-Le_Caignec_syndrome (38 variants)
- SOX6-related_disorder (13 variants)
- not_specified (9 variants)
- Neurodevelopmental_disorder (3 variants)
- Craniosynostosis_syndrome (1 variants)
- Intellectual_disability (1 variants)
- See_cases (1 variants)
- Developmental_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SOX6 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001367873.1. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 20 | 8 | 31 | ||
| missense | 2 | 8 | 150 | 17 | 5 | 182 |
| nonsense | 7 | 5 | 12 | |||
| start loss | 0 | |||||
| frameshift | 6 | 4 | 5 | 15 | ||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | |||
| Total | 16 | 17 | 160 | 37 | 13 |
Highest pathogenic variant AF is 0.000004348458
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SOX6 | protein_coding | protein_coding | ENST00000396356 | 15 | 773144 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125595 | 0 | 2 | 125597 | 0.00000796 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.93 | 339 | 455 | 0.746 | 0.0000262 | 5311 |
| Missense in Polyphen | 124 | 207.55 | 0.59744 | 2358 | ||
| Synonymous | 0.162 | 167 | 170 | 0.984 | 0.00000975 | 1560 |
| Loss of Function | 5.48 | 4 | 42.6 | 0.0939 | 0.00000222 | 471 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000291 | 0.0000291 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.00000881 | 0.00000881 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator. Binds specifically to the DNA sequence 5'-AACAAT-3'. Plays a key role in several developmental processes, including neurogenesis and skeleton formation.;
- Pathway
- NOTCH1 regulation of human endothelial cell calcification;Endochondral Ossification;Signaling by WNT;Signal Transduction;Deactivation of the beta-catenin transactivating complex;TCF dependent signaling in response to WNT
(Consensus)
Recessive Scores
- pRec
- 0.188
Intolerance Scores
- loftool
- 0.00909
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.72
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.372
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Zebrafish Information Network
- Gene name
- sox6
- Affected structure
- fast muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- process quality
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;cell morphogenesis;in utero embryonic development;regulation of transcription, DNA-templated;muscle organ development;post-embryonic development;gene silencing;oligodendrocyte cell fate specification;positive regulation of chondrocyte differentiation;cell fate commitment;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;astrocyte differentiation;erythrocyte development;cartilage development;cardiac muscle cell differentiation;positive regulation of cartilage development;cellular response to transforming growth factor beta stimulus;negative regulation of cardiac muscle cell differentiation;positive regulation of mesenchymal stem cell differentiation
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;protein heterodimerization activity